Produkty 108340-60-9

CAS 108340-60-9 występuje w naszej ofercie pod nazwami: Ganoderic acid D/ 98.06% (existing batch purity), Ganoderic Acid D, Ganoderic acid D, Ganoderic acid D (Standard), Ganoderic acid D, 99.40%. Oferty producentów: TargetMol, GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, Get quote, 5 mg, 1 mg.

Ganoderic acid D/ 98.06% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg
  • Warianty: 3
od 445,96
Zobacz produkt
Ganoderic Acid D
GLPBio
  • opakowanie: 1mg, 10mg, 25mg, 5mg
  • Warianty: 4
od 620,44
Zobacz produkt
Ganoderic acid D
Biosynth, Chemat
  • opakowanie: 1mg, 5mg, 25mg, 50mg
  • Warianty: 5
od 611,60
Zobacz produkt
Ganoderic acid D (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Ganoderic acid D, 99.40%
MedChemExpress
  • opakowanie: 5 mg, 1 mg, 10mM/1mL, 25 mg
  • Warianty: 5
od 361,49
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

2-methyl-4-oxo-6-(3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid (CAS 108340-60-9) to związek chemiczny o wzorze sumarycznym C30H44O8 i masie molowej 532.7 g/mol. Nazwa systematyczna IUPAC: 2-methyl-4-oxo-6-(3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid. InChIKey: BPJPBLZKOVIJQD-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H44O8
Masa molowa532.7 g/mol
Nazwa IUPAC2-methyl-4-oxo-6-(3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
InChIKeyBPJPBLZKOVIJQD-UHFFFAOYSA-N
SMILESCC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Ganoderic Acid D, GanodericAcidG, Ganoderic Acid G [M+H]+, 3,7,12-Trihydroxy-11,15,23-trioxolanost-8-en-26-oic acid, 3|?,7|?,12|?-Trihydroxy-11,15,23-trioxo-5| cent-lanost-8-en-26-oic acid
Powiązane formy tego związku
(6R)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid C30H44O8
Izomery (ten sam wzór sumaryczny)
(1R,2R,4R,5R,6S,7S,9R,10S,11S,13S,14R,15R,25R)-10,11-dihydroxy-9-(hydroxymethyl)-2,13,15-trimethyl-4-prop-1-en-2-yl-8,24,26,27-tetraoxaheptacyclo[12.10.1.14,23.15,23.01,6.07,9.011,25]heptacosan-12-one C30H44O8
3-[6-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-9,13-dimethyl-17-oxo-14-tetracyclo[11.3.1.01,10.04,9]heptadecanyl]-2H-furan-5-one C30H44O8
[(2S,3R,4S)-2-[(3R,4aR,6aR,12S,12aS,12bR)-12-hydroxy-3-(2-hydroxypropan-2-yl)-6a,12b-dimethyl-8,11-dioxo-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthen-9-yl]-4-methylhexan-3-yl] acetate C30H44O8
(2R,6S)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid C30H44O8
(E,4S,6R)-4-hydroxy-2-methyl-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-2-enoic acid C30H44O8